Stallion India Fluorochemicals Reports Strong Q2 FY26 Unaudited Financial Results
Stallion India Fluorochemicals reported strong unaudited financial results for Q2 FY26 and H1 FY26, with significant growth in total income, PBT, PAT, and EPS compared to the previous year.
The significant improvement in both quarterly and half-yearly financial performance, particularly the massive increase in profitability metrics like PBT and PAT, is a strong positive indicator for investors and is likely to have a high impact on the company's stock price and market perception.
The company demonstrated substantial growth across all key financial metrics for both the quarter and half year ended September 30, 2025. Total income, profit before tax, profit after tax, and EPS all saw significant increases compared to the previous year, indicating strong operational performance and profitability.
Stallion India Fluorochemicals Limited has published its unaudited financial results for the quarter and half year ended 30 September, 2025, as approved by its Board of Directors on 13 October, 2025. The key financial highlights are:
* Total Income from operations for the quarter ended 30 September, 2025, significantly increased to ₹10,556.41 lakhs, up from ₹6,756.47 lakhs in the same quarter last year. * The company reported a Profit Before Tax (PBT) of ₹1,524.13 lakhs for the quarter ended 30 September, 2025, a substantial rise from ₹55.07 lakhs in the corresponding quarter of the previous year. * Profit After Tax (PAT) for the quarter stood at ₹1,141.67 lakhs, compared to ₹85.12 lakhs in the quarter ended 30 September, 2024. * Basic Earnings Per Share (EPS) for the quarter improved significantly to ₹1.42 from ₹0.14.
For the half year ended 30 September, 2025: * Total Income from operations was ₹21,603.60 lakhs. * Profit Before Tax (PBT) reached ₹2,910.27 lakhs. * Profit After Tax (PAT) was ₹2,178.00 lakhs. * Basic EPS for the half year was ₹2.73.
The detailed financial results are available on the websites of BSE (www.bseindia.com), NSE (www.nseindia.com), and the Company's website (www.stallionfluorochemicals.com).
What to do with a filing like this
Stallion India Fluorochemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Stallion India Fluorochemicals Limited. Read the original for the full detail.